Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study

被引：7
|
作者：
Cazzaniga, M. E. [1 ]
Mustacchi, G. [2 ]
Pronzato, P. [3 ]
De Matteis, A. [4 ]
Di Costanzo, F. [5 ]
Floriani, I. [6 ]
机构：
[1] Treviglio Hosp, I-24047 Treviglio, BG, Italy
[2] Univ Trieste, Dept Med Oncol, Trieste, Italy
[3] IST, Genoa, Italy
[4] Ist Pascale, Naples, Italy
[5] Osped Careggi, Florence, Italy
[6] Ist Ric Farmacol Mario Negri, Dept Oncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷 / 12期
关键词：
adjuvant therapy; breast cancer; St Gallen recommendations;
D O I：
10.1093/annonc/mdm365
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: The NORA study is a prospective longitudinal cohort study aiming at investigating treatment in patients with early breast cancer. Here, we present the impact of the St Gallen recommendations on clinical practice. Patients and methods: We compared adjuvant strategies in patients enrolled in 2000-2002 to those in 2003-2004 to verify the impact of the 2003 St Gallen recommendations. Results: The use of aromatase inhibitors (Als) doubled: 65/629 patients (10.3%) vs 100/458 patients (21.8) (P < 0.0001). Following chemotherapy, Als were administered in 8.5% of the retrospective cohort and in 15.1 % of the prospective one (P < 0.0001). The use of taxanes plus hormones dropped (P = 0.0026), but not when used as single agents. A marked increase was observed in the use of anthracycline-based chemotherapy (46.3% vs 65.2%), mainly three-drug regimens (33.3% vs 46.6%). Conclusion: Our results suggest that the St Gallen recommendations have had a major impact on clinical practice.
引用
收藏
页码：1976 / 1980
页数：5
相关论文
共 50 条
  • [21] Are international guidelines for the prescription of adjuvant treatment for early breast cancer followed in clinical practice? Results of a population-based study on 1547 patients
    Palazzi, M
    De Tomasi, D
    D'Affronto, C
    Richetti, A
    Valli, MC
    Meregalli, S
    Asnaghi, D
    Arienti, V
    Cavallini, D
    Pradella, R
    Cafaro, I
    Baroncelli, G
    Di Lorenzo, I
    De Agostini, A
    Parrinello, G
    Bertoni, F
    TUMORI, 2002, 88 (06) : 503 - 506
  • [22] Validation and problems of St-Gallen recommendations of adjuvant therapy for node-negative invasive breast cancer in Japanese patients
    Iwamoto, E
    Fukutomi, T
    Akashi-Tanaka, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (06) : 259 - 262
  • [23] Adjuvant endocrine therapy for breast cancer. Updated aspects from new study results, ASCO 2004, and the St. Gallen consensus statements of 2005
    Cordes, T.
    Schutze-Mosgau, A.
    Finas, D.
    Friedrich, M.
    Diedrich, K.
    Diesing, D.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2005, 3 (02): : 78 - 84
  • [24] Changes in Adjuvant Treatment of Early Breast Cancer in Italy between 2000 and 2008. The NEMESI Study Versus the NORA Study.
    Mustacchi, G.
    Cazzaniga, M. E.
    Pronzato, P.
    Clavarezza, M.
    Del Mastro, L.
    Venturini, M.
    Amadori, D.
    Bidoli, P.
    Boni, C.
    Caruso, M.
    Riccardi, F.
    Dondi, D.
    CANCER RESEARCH, 2011, 71
  • [25] Do treatment recommendations from a multidisciplinary breast cancer conference differ from established practice guidelines?
    Andersen, JC
    Fabian, CJ
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 249 - 249
  • [26] Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice
    Swanick, Cameron W.
    Smith, Benjamin D.
    CHINESE CLINICAL ONCOLOGY, 2016, 5 (03)
  • [27] Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
    Goldhirsch, A.
    Winer, E. P.
    Coates, A. S.
    Gelber, R. D.
    Piccart-Gebhart, M.
    Thuerlimann, B.
    Senn, H. -J.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2206 - 2223
  • [28] Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
    Hadji, P.
    Coleman, R. E.
    Wilson, C.
    Powles, T. J.
    Clezardin, P.
    Aapro, M.
    Costa, L.
    Body, J. -J.
    Markopoulos, C.
    Santini, D.
    Diel, I.
    Di Leo, A.
    Cameron, D.
    Dodwell, D.
    Smith, I.
    Gnant, M.
    Gray, R.
    Harbeck, N.
    Thurlimann, B.
    Untch, M.
    Cortes, J.
    Martin, M.
    Albert, U. -S.
    Conte, P. -F.
    Ejlertsen, B.
    Bergh, J.
    Kaufmann, M.
    Holen, I.
    ANNALS OF ONCOLOGY, 2016, 27 (03) : 379 - 390
  • [29] A retrospective study of do-not-do practice recommendations in metastatic breast cancer in Spain
    Vega, Iranzo Gonzalez-Cruz
    Rescalvo, M. Angeles Garcia
    Moreno, Fernando
    Ballester, Pura
    Guisado, Antonia Martinez
    Siso, Christian
    Pena, Alejandra
    Mira, Jose Joaquin
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2024, 37 (03):
  • [30] Variation from clinical guideline recommendations in practice patterns of community based adjuvant hormonal therapy (AHT) in early stage breast cancer (ESBC).
    Schwartzberg, L. S.
    Cobb, P.
    Kulig, K.
    Johns, A.
    Fu, D-Y
    Fortner, B., V
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S196 - S197
12345